High Performance Computing (HPC) Enabled Research into Covid-19
The Advanced Computing Research Centre has supported important research into Covid-19 through its HPC resources. The list below showcases specific examples of this.
Omics analysis of SARS-CoV2 and the Oxford/AstraZeneca vaccine
Prof David Matthews and his team used BlueCrystal4 as part of their work to examine the AstraZenica/Oxford vaccine to understand exactly what instructions (known as mRNA) and proteins they made.
Changes in mental health across COVID-19 - genetic and environmental determinants
Alex Kwong and team utilised BlueCrystal3 in their work examining how genetic liability to psychiatric traits like depression and anxiety might affect mental health during COVID-19 restrictions.
Non-equilibrium simulations of the SARS-CoV2 spike protein 
Dr Sofia Oliveira utilised HPC clusters on BlueCrystal4 and Catalyst, as well as the Oracle cloud, to run equilibrium and nonequilibrium molecular dynamics simulations.
@BristolUni_ACRC
Follow us! keep up with what the ACRC are doing via our twitter.
Further HPC Enabled Research
There are many more examples of HPC enabled research within the Univerversity of Bristol.
Covid-19 Mapping and Mitigation in Schools (CoMMinS)
As part of the CoMMinS study, Caroline Renton utilised BlueCrystal3 in their research to better understand Covid-19 infection dynamics centred around schools.